Berkshire Capital Holdings’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10	Closed	-$1K	–	79
2021 Q3	$1K	Sell	10 -56,910	-100%	-$5.69M	﹤0.01%	65
2021 Q2	$9.22M	Buy	56,920 +56,910	+569,100%	+$9.21M	1.08%	28
2021 Q1	$1K	Buy	+10	New	+$1K	﹤0.01%	70